Clik here to view.
St. Jude enrolls first patient into heart rhythm early intervention trial |...
St. Jude Medical Inc. (NYSE:STJ) enrolled the first patient into its pan-European study of early interventions of irregular heartbeat. St. Jude can enroll more than 3,000 patients across 200 centers...
View ArticleClik here to view.
Valeritas completes $150 million in Series C
Valeritas Announces $150 Million Financing Welsh, Carson, Anderson & Stowe led the financing and assumes a controlling interest in Valeritas Financing will support the commercialization of the...
View ArticleClik here to view.
Miracor secures $10 million in series B | Funding Roundup
Private medical device company, Miracor Medical Systems GmbH, secured $10 million in the first closing of the series B financing round. Second closing is pending approval by investors. Austria...
View ArticleClik here to view.
Diabetes: Valeritas lands $100M fund for insulin delivery system
Diabetes devices maker Valeritas announced today that it closed a structured debt financing with $100 million to support commercial efforts of its V-Go insulin delivery system. The new funding adds to...
View ArticleClik here to view.
Diabetes: Valeritas registers $90m IPO
Valeritas yesterday registered for an initial public offering worth up to $90 million for its V-Go insulin delivery system. Bridgewater, N.J.-based Valeritas said it plans to list on the NASDAQ...
View ArticleClik here to view.
SNN invests in Michelson’s Series B | Medtech funding for the week of...
Smith & Nephew gets in on Michelson Diagnostics Series B round February 16, 2015 by Brad Perriello Smith & Nephew put down the cornerstone in the 1st tranche of Michelson Diagnostics’ $3.8...
View ArticleClik here to view.
Diabetes: Valeritas sets terms for $75m IPO
Valeritas yesterday set the terms for its forthcoming initial public offering, saying it plans to put up 5 million shares at $14 to $16 each. At the midpoint of the range, the IPO would fetch $75...
View ArticleClik here to view.
Valeritas sets terms for $75m IPO | Medtech Wall Street news for the week of...
Diabetes: Valeritas sets terms for $75m IPO March 10, 2015 by Brad Perriello Valeritas yesterday set the terms for its forthcoming initial public offering, saying it plans to put up 5 million shares...
View ArticleClik here to view.
Diabetes: Valeritas delays $75m IPO
Valeritas today postponed its planned initial public offering, which at the midpoint was slated to fetch $75 million for its V-Go basal insulin delivery system for Type II diabetes, Renaissance...
View ArticleClik here to view.
Valeritas touts real-world V-Go data
Valeritas touted real-world data from 3 separate studies of its V-Go insulin delivery system showcasing the device’s utility and effectiveness. V-Go is a disposable, wearable insulin delivery device...
View ArticleClik here to view.
Diabetes: Medtronic furthers the quest for an artificial pancreas
Medtronic (NYSE:MDT) and Intarcia Therapeutics were in the spotlight at the American Diabetes Assn.’s annual scientific sessions conference in Boston last week, revealing new medical device...
View ArticleClik here to view.
Diabetes: Valeritas touts V-Go insulin pump study data
Valeritas said today that data from a study of its V-Go insulin pump showed a significant decrease in A1C levels after 14 and 27-week follow-up visits. Data from the study was published in the journal...
View ArticleClik here to view.
RIP medical device pioneer Alfred Mann | Personnel Moves
Alfred Mann, a medical device entrepreneur who helped develop several groundbreaking technologies, died yesterday at age 90, shortly after stepping down from a pair of companies he founded. Mann...
View ArticleClik here to view.
Valeritas spikes $75m IPO
Nearly a year after tabling a proposed initial public offering, Valeritas today formally withdrew the planned flotation in a regulatory filing. “The market conditions have been such that the offering...
View ArticleClik here to view.
Flex taps ex J&J med device R&D exec Carlson for Flex Med Solutions prez |...
Flex taps ex J&J med device R&D exec Carlson for Flex Med Solutions prez Flex (NSDQ:FLEX) said it hired ex-Johnson & Johnson (NYSE:JNJ) innovation portfolio veep as its new president of...
View ArticleClik here to view.
Valeritas raises $25m via reverse merger, private placement
Valeritas said today it raised $25 million through an “alternative public offering” via a reverse merger and the private placement of 5 million shares of unregistered stock at $5 per share. Through the...
View ArticleClik here to view.
Getinge ousts CEO Myers after 18 months, shares slide | Personnel Moves...
Getinge ousts CEO Myers after 18 months, shares slide After less than 18 months in the corner office, Getinge (PINK:GETI B) has removed CEO Alex Myers from his position, sending shares down as much as...
View ArticleClik here to view.
Xtant Medical chief Goldberger bows out | Personnel Moves, January 23, 2016
Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.” The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for...
View ArticleClik here to view.
Valeritas rekindles IPO plans, aims for $50m
Valeritas yesterday rekindled its plans for an initial public offering, but scaled its ambitions back by some $25 million. Bridgewater, N.J.-based Valeritas makes the V-Go basal insulin delivery system...
View ArticleClik here to view.
Report: Insulin delivery devices improve adherence, lower costs
Valeritas (NSDQ:VLRX) touted data today from a publication detailing the benefits of diabetes medication delivery devices, such as the company’s V-Go insulin delivery system. The article was published...
View Article
